D G Sherman Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

1/2001

Antithrombotic therapy in the acute phase: new approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D G Sherman Research Topics

Disease

2	Stroke (Strokes) 01/2001 - 05/2000
2	Ischemic Stroke 01/2001 - 05/2000
2	Hemorrhage 01/2001 - 05/2000
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2000

Drug/Important Bio-Agent (IBA)

1	Fibrinogen (Factor I)FDA Link 01/2001
1	Heparin (Liquaemin)FDA LinkGeneric 01/2001
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2001
1	Heparinoids (Heparinoid)IBA 01/2001
1	danaparoid (Orgaran)FDA Link 01/2001
1	AnticoagulantsIBA 01/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2001
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2001
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2000
1	Ancrod (Arvin)IBA 05/2000

Therapy/Procedure

1	Time-to-Treatment 05/2000
1	Intravenous Infusions 05/2000